Physician profile
Kyle B Mckey
NPI 1205360062
$2,365.16
in general payments reported to CMS, 2019-2025
12 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $118 · 2021: $824 · 2022: $841 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $722.23 | 2020-2025 | Hydrus Microstent |
| Glaukos Corporation | $495.70 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $226.21 | 2019-2022 | |
| Alcon Research LLC | $156.08 | 2025 | Air Optix |
| Oyster Point Pharma, INC. | $154.19 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $136.49 | 2021-2025 | Tecnis Iol |
| Eyepoint US, INC. | $123.94 | 2022 | |
| Mallinckrodt Hospital Products INC. | $106.25 | 2022 | |
| Carl Zeiss Meditec Cataract Technology INC. | $105.76 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.00 | 2019 | |
| Biotissue Holdings INC. | $19.66 | 2022 | |
| Horizon Therapeutics Plc | $18.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Mckey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.